These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

399 related items for PubMed ID: 30627979

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Potential value of FDG PET-CT in predicting occult lymph node metastasis in clinical stage ⅠA lung adenocarcinoma].
    Lyu L, Liu Y, Wang XY, Zhang ZK, Tao XL, Yang L, Wu N.
    Zhonghua Zhong Liu Za Zhi; 2019 Jun 23; 41(6):441-447. PubMed ID: 31216830
    [Abstract] [Full Text] [Related]

  • 8. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification predicts occult lymph node metastasis in clinically mediastinal node-negative lung adenocarcinoma.
    Yeh YC, Kadota K, Nitadori J, Sima CS, Rizk NP, Jones DR, Travis WD, Adusumilli PS.
    Eur J Cardiothorac Surg; 2016 Jan 23; 49(1):e9-e15. PubMed ID: 26377636
    [Abstract] [Full Text] [Related]

  • 9. Oncologic outcomes of segmentectomy compared with lobectomy for clinical stage IA lung adenocarcinoma: propensity score-matched analysis in a multicenter study.
    Tsutani Y, Miyata Y, Nakayama H, Okumura S, Adachi S, Yoshimura M, Okada M.
    J Thorac Cardiovasc Surg; 2013 Aug 23; 146(2):358-64. PubMed ID: 23477694
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Risk factors for lymph node metastasis and surgical methods in patients with early-stage peripheral lung adenocarcinoma presenting as ground glass opacity.
    Wang Y, Jing L, Wang G.
    J Cardiothorac Surg; 2020 Aug 12; 15(1):121. PubMed ID: 32782020
    [Abstract] [Full Text] [Related]

  • 16. Predictive factors for node metastasis in patients with clinical stage I non-small cell lung cancer.
    Cho S, Song IH, Yang HC, Kim K, Jheon S.
    Ann Thorac Surg; 2013 Jul 12; 96(1):239-45. PubMed ID: 23673071
    [Abstract] [Full Text] [Related]

  • 17. Prognostic factors of lung adenocarcinoma manifesting as ground glass nodules larger than 3 cm.
    Ding H, Wang H, Zhang P, Song N, Chen L, Jiang G.
    Eur J Cardiothorac Surg; 2019 Jun 01; 55(6):1130-1135. PubMed ID: 30561606
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A prediction model for N2 disease in T1 non-small cell lung cancer.
    Zhang Y, Sun Y, Xiang J, Zhang Y, Hu H, Chen H.
    J Thorac Cardiovasc Surg; 2012 Dec 01; 144(6):1360-4. PubMed ID: 22819364
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.